Mayoly Spindler annuncia l'acquisizione di Ipsen Consumer Healthcare – Mayoly
Dassault Systèmes and Ipsen Sign Collaborative Agreement to Develop Innovative Programs to Support Ipsen's Drug Discovery | Business Wire
IPC Award
Ipsen to acquire exclusive rights to investigational ERK inhibitor as part of its existing research collaboration with AGV Discovery | Liberi Group
Ipsen announced overall Pharma Industry Company of the Year in 2021 Pharma Industry Awards - Ipsen UK
With New HQ, Ipsen to Rapidly Expand North American Presence - NAI 500
How Ipsen is making patient-centric innovation a reality - Ipsen
Innovation for patient care: NAYADA for Ipsen Farma office
Ipsen – Cartellina gamma prodotti – The Bear
PharmaShots Interview: Ipsen's Dr. Med. Steven Hildemann Shares Insight on the EC's Approval of Cabometyx + Nivolumab for Advanced Renal Cell Carcinoma
Ipsen - Innovation for patient care - Ipsen
IPSEN Innovation for patient care CONSUMER HEALTHCARE Trademark of IPSEN. Application Number: 018252374 :: Trademark Elite Trademarks
Ipsen (@IpsenGroup) / Twitter
INFORMATORE MEDICO SCIENTIFICO - Ipsen Consumer HealthCare srl - 24/03/2022 - informatori-scientifici.it
Ipsen Patient Centricity Showreel Oncology - EN - YouTube
Ipsen on Twitter: "Ipsen's patient-centric vision uses deep insights from patients to tackle the challenges they face in the healthcare ecosystem. David Loew explains this approach to @PharmaBoardroom. Read more here: https://t.co/Anfe3eJewx #
Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology
Stephane Brocker
Leipziger Psycholog:innen gewinnen „IPC - Innovation for Patient Care Award“
Stewart Campbell on LinkedIn: Partner Opportunities | Ipsen Biopharmaceuticals | Drive Innovation
